Zorronet launches no-code workflow builder for AI security platforms

Zorronet Ltd., a subsidiary of BiomX Inc. (NYSE American: PHGE), has launched a no-code visual interface that allows security operators to build and modify autonomous response workflows on its AI-powered command-and-control platform without programming support. The capability, announced on 4 September 2026, lets users connect cameras, sensors, drones, gates and other on-site hardware into coordinated response logic using a drag-and-connect builder.

BiomX itself is mid-transition: the company is set to rename as Tessera Defense and Homeland Security Inc. on 11 September 2026, with the ticker shifting from PHGE to HLSQ on NYSE American. The renaming signals a broader strategic repositioning away from the firm's original biopharmaceutical focus toward defense, homeland security and critical infrastructure technology.

What the platform does

The Zorronet builder works by presenting pre-built capability blocks, each representing a connected asset or analytical function. Operators link these blocks to create site-specific operational logic. A single deployment can run multiple parallel workflows: one for a perimeter fence at night, a separate one for a delivery gate at weekends, another for a car park during working hours. Each workflow runs its own logic and manages its own assigned assets.

The range of connectable blocks is broad. The platform supports cameras, radar units, PTZ systems, drones, electric gates, PLC controllers, public-address systems, acoustic sensors, facial recognition modules, OSINT feeds and vision-language analysis tools. Once connected, these devices are managed through a single AI command layer that interprets field events and coordinates responses in real time.

A key design choice is the human-in-the-loop option. Workflows can be configured to pause at defined decision points and require one-click operator approval before an action executes. Fully autonomous operation is also available, with the same interface controlling both modes.

Idan Wasserman, chief executive of Zorronet, said: "They can define, adapt and run multiple operational workflows themselves as conditions and requirements change." BiomX chief executive Michael Oster added that the acquisition of Zorronet was predicated on the value of unifying disparate sensor inputs through a single AI decision layer, rather than relying on individual devices.

Market context and regulatory exposure

The physical security software market has moved steadily toward unified command platforms. Traditional video management systems are being supplemented or replaced by AI orchestration layers that can correlate inputs across sensor types and automate initial response steps. Competitors in this space range from large established vendors such as Genetec and Milestone Systems to a growing field of AI-native challengers targeting critical infrastructure and government clients.

Zorronet's platform is already deployed in defense, homeland security and municipal environments in Israel, according to the release. The company says the software can run on-premises inside hardened networks or through the cloud, which matters considerably for government and defense procurement where data-sovereignty and air-gap requirements are common.

The capability set disclosed in the release carries significant regulatory exposure. Facial recognition, biometric data processing and autonomous decision-making in physical security contexts fall under a patchwork of privacy and export-control frameworks. In the European Union, the AI Act classifies real-time biometric identification systems in public spaces as high-risk or, in certain cases, prohibited, depending on use. US Bureau of Industry and Security export controls govern the transfer of dual-use surveillance technologies. The company's own risk disclosures note obligations under "privacy, data protection, biometric and export control requirements." Potential customers in regulated markets will need to conduct careful compliance assessments before deployment.

Investors will also note that BiomX's filing disclosures reference a going-concern qualification and the risk of NYSE American delisting, which adds financial uncertainty to a company pitching a platform with an ambitions-forward product roadmap.